Header Logo

JAMES P ALLISON

Concepts (936)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JAMES P ALLISON's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JAMES P ALLISON has written about over time.
Receptors, Antigen, T-Cell, 44 publications between 1983 and 2021, average publication date June 1997. CD28 Antigens, 25 publications between 1992 and 2016, average publication date November 2002. T-Lymphocytes, 83 publications between 1983 and 2021, average publication date August 2003. B7-1 Antigen, 19 publications between 1993 and 2011, average publication date November 2003. Antigens, Differentiation, 28 publications between 1997 and 2011, average publication date February 2005. Antigens, CD, 51 publications between 1992 and 2011, average publication date June 2005. Antibodies, Monoclonal, 71 publications between 1982 and 2022, average publication date June 2006. Lymphocyte Activation, 57 publications between 1978 and 2021, average publication date December 2006. Receptors, Immunologic, 14 publications between 1987 and 2024, average publication date September 2007. T-Lymphocyte Subsets, 24 publications between 1991 and 2021, average publication date May 2009. CD4-Positive T-Lymphocytes, 32 publications between 1993 and 2024, average publication date August 2011. Melanoma, Experimental, 17 publications between 2004 and 2021, average publication date March 2012. CTLA-4 Antigen, 90 publications between 1997 and 2024, average publication date April 2012. Inducible T-Cell Co-Stimulator Protein, 11 publications between 2005 and 2024, average publication date May 2013. Immunotherapy, 69 publications between 1994 and 2024, average publication date June 2013. T-Lymphocytes, Regulatory, 32 publications between 2006 and 2024, average publication date October 2013. CD8-Positive T-Lymphocytes, 47 publications between 1994 and 2024, average publication date March 2014. Neoplasms, 59 publications between 1995 and 2024, average publication date June 2014. Ipilimumab, 41 publications between 2007 and 2024, average publication date June 2015. Programmed Cell Death 1 Receptor, 27 publications between 2003 and 2024, average publication date May 2016.

To see the data from this visualization as text, click here.
ALLISON's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (936)
Explore
_
Co-Authors (262)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_